一本大道无码,麻豆文化传媒www网站入口,噜噜国产精品,亚洲高潮性爱免费久久视频

AZD8330

    
98%

2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide

源葉(MedMol)
S81035 一鍵復(fù)制產(chǎn)品信息
869357-68-6
C16H17FIN3O4
461.23
貨號(hào) 規(guī)格 價(jià)格 上海 北京 武漢 南京 購(gòu)買(mǎi)數(shù)量
S81035-1mg 98% ¥280.00 4 - - -
S81035-2mg 98% ¥400.00 5 - - -
S81035-5mg 98% ¥632.00 5 - - -
S81035-10mg 98% ¥1200.00 5 - - -
S81035-25mg 98% ¥2080.00 2 - - -
S81035-50mg 98% ¥3600.00 貨期:2-3天 - - -
S81035-100mg 98% ¥5200.00 貨期:2-3天 - - -
產(chǎn)品介紹 參考文獻(xiàn) 質(zhì)檢證書(shū)(COA) 摩爾濃度計(jì)算器 相關(guān)產(chǎn)品

產(chǎn)品介紹

AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM.

產(chǎn)品描述: AZD8330 (ARRY-424704) is a potent, uncompetitive MEK1/MEK2 inhibitor, with an IC50 of 7 nM.
靶點(diǎn): MEK1:7 nM (IC50);MEK2:7 nM (IC50);ERK;?MEK
體內(nèi)研究: In tumour xenograft models, AZD8330 demonstrates dose-dependent tumour growth inhibition of approximately 90% at tolerated doses (1.0 mg/kg once daily [OD])
參考文獻(xiàn): 1. Cohen RB, et al. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9. 2. Baranski Z, et al. MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation. Genes Cancer. 2015 Nov;6(11-12):503-12.
溶解性: DMSO  :  ≥  100  mg/mL  (216.81  mM)
保存條件: -20℃
配置溶液濃度參考:
1mg 5mg 10mg
1 mM 2.168 ml 10.841 ml 21.681 ml
5 mM 0.434 ml 2.168 ml 4.336 ml
10 mM 0.217 ml 1.084 ml 2.168 ml
50 mM 0.043 ml 0.217 ml 0.434 ml
注意: 部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。

參考文獻(xiàn)

質(zhì)檢證書(shū)(COA)

如何獲取質(zhì)檢證書(shū)(COA)?
請(qǐng)輸入貨號(hào)和一個(gè)與之匹配的批號(hào)。
例如:
批號(hào):JS298415 貨號(hào):S20001-25g
在貨品標(biāo)簽上如何找到貨號(hào)和批號(hào)?

摩爾濃度計(jì)算器

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關(guān)產(chǎn)品